Jackson Acquisition Company II is a Special Purpose Acquisition Company (SPAC) that completed its initial public offering in December 2024, raising $230 million. Headquartered in Alpharetta, Georgia, the company operates as a blank-check vehicle with no commercial operations or products of its own. Its primary objective is to identify, acquire, or merge with one or more private businesses, leveraging the extensive healthcare and investment expertise of its management team and sponsor.
As a pre-deal SPAC, the company generates no operating revenue; its net income is entirely derived from interest earned on the IPO proceeds held in a trust account. While Jackson Acquisition Company II is permitted to pursue a business combination in any sector or geographic location, its strategic focus is concentrated on the healthcare industry. Specifically, the firm targets consumer-oriented and technology-enabled enterprises within healthcare services and healthcare technology, primarily in North America. The company is currently in its pre-combination phase and actively seeking a target that can benefit from public market access, operational expertise, and strategic capital support before its mandatory liquidation deadline.
